JNJ

ORTHO-CLINICAL DIAGNOSTICS SA — Moody’s: Ortho-Clinical’s increased bond offering is credit negative

moreView todays social media effects on JNJView the latest stocks trending across Twitter. Click to view dashboardSee who Johnson is hiring next, click here to view […]

May 8, 2014 Bystocknews JNJ, stock Comments Off read more

Fitch Revises Bayer AG’S Outlook to Negative; Affirms at ‘A’

[Reuters – UK Focus] – Fitch Ratings has revised Germany-based healthcare company Bayer AG’s Outlook to Negative from Stable. The agency has also affirmed its Long-term Issuer Default Rating and senior unsecured rating at ‘A’, … moreView todays social media effects on JNJView the latest stocks trending across Twitter. Click to view dashboardSee who Johnson is hiring next, click here […]

May 8, 2014 Bystocknews JNJ, stock Comments Off read more

Johnson & Johnson Is Rewarding but Too Expensive

moreView todays social media effects on JNJView the latest stocks trending across Twitter. Click to view dashboardSee who Johnson is hiring next, click here to view […]

May 8, 2014 Bystocknews JNJ, stock Comments Off read more

Allergan Reports Strong Q1 While Weighing Valeant Bid

moreView todays social media effects on JNJView the latest stocks trending across Twitter. Click to view dashboardSee who Johnson is hiring next, click here to view […]

May 7, 2014 Bystocknews JNJ, stock Comments Off read more

Are stocks overpriced?

moreView todays social media effects on JNJView the latest stocks trending across Twitter. Click to view dashboardSee who Johnson is hiring next, click here to view […]

May 7, 2014 Bystocknews JNJ, stock Comments Off read more

7:48 am Johnson & Johnson’s Janssen submits snDA to FDA for OLYSIO (simeprevir) for once-daily use in combinaiton with sofosbuvir for 12 weeks for the treatment of adult patients with genotype 1 chronic hepatitis C

moreView todays social media effects on JNJView the latest stocks trending across Twitter. Click to view dashboardSee who Johnson is hiring next, click here to view […]

May 7, 2014 Bystocknews JNJ, stock Comments Off read more

ORTHO-CLINICAL DIAGNOSTICS SA — Moody’s: Ortho-Clinical’s increased bond offering is credit negative

Fitch Revises Bayer AG’S Outlook to Negative; Affirms at ‘A’

Johnson & Johnson Is Rewarding but Too Expensive

Allergan Reports Strong Q1 While Weighing Valeant Bid

Are stocks overpriced?

7:48 am Johnson & Johnson’s Janssen submits snDA to FDA for OLYSIO (simeprevir) for once-daily use in combinaiton with sofosbuvir for 12 weeks for the treatment of adult patients with genotype 1 chronic hepatitis C

How the Dow Jones industrial average fared Tuesday

[$$] European Physicians Study Risks of a Uterine Surgical Method

Don’t Be An Arrogant Dividend Growth Investor

Earnings Preview: Allergan up almost 50% since last earnings report